Your browser doesn't support javascript.
loading
Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia.
Chalandon, Yves; Thomas, Xavier; Hayette, Sandrine; Cayuela, Jean-Michel; Abbal, Claire; Huguet, Françoise; Raffoux, Emmanuel; Leguay, Thibaut; Rousselot, Philippe; Lepretre, Stéphane; Escoffre-Barbe, Martine; Maury, Sébastien; Berthon, Céline; Tavernier, Emmanuelle; Lambert, Jean-François; Lafage-Pochitaloff, Marina; Lhéritier, Véronique; Chevret, Sylvie; Ifrah, Norbert; Dombret, Hervé.
Afiliación
  • Chalandon Y; Division of Hematology, Department of Medical Specialties, University Hospital and University of Geneva, Geneva, Switzerland; Swiss Group for Clinical Cancer Research, Bern, Switzerland;
  • Thomas X; Division of Hematology, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre Bénite, France;
  • Hayette S; Division of Hematology, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre Bénite, France;
  • Cayuela JM; Division of Hematology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, University Paris Diderot, Paris, France;
  • Abbal C; Division of Hematology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland;
  • Huguet F; Division of Hematology, Institut Universitaire de Cancérologie, Toulouse, France;
  • Raffoux E; Division of Hematology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, University Paris Diderot, Paris, France;
  • Leguay T; Division of Hematology, Hôpital Haut-Levêque, Pessac, France;
  • Rousselot P; Division of Hematology, Hôpital Mignot, Versailles, France;
  • Lepretre S; Division of Hematology, Centre Henri Becquerel, Rouen, France;
  • Escoffre-Barbe M; Division of Hematology, Hôpital Pontchailloux, Rennes, France;
  • Maury S; Division of Hematology, Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris, University Paris Est Créteil, Créteil, France;
  • Berthon C; Division of Hematology, Hôpital Claude Huriez, Lille, France;
  • Tavernier E; Division of Hematology, Institut de Cancérologie Lucien-Neuwirth, Saint-Priest-en-Jarez, France;
  • Lambert JF; Swiss Group for Clinical Cancer Research, Bern, Switzerland; Division of Hematology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland;
  • Lafage-Pochitaloff M; Division of Hematology, Hôpital de la Timone, Marseille, France;
  • Lhéritier V; Group for Research on Adult Acute Lymphoblastic Leukemia, Lyon, France;
  • Chevret S; Division of Biostatistics, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, University Paris Diderot, Paris, France; and.
  • Ifrah N; Division of Hematology, Centre Hospitalier Universitaire d'Angers and INSERM U892/Centre National de la Recherche Scientifique 6299, Angers, France.
  • Dombret H; Division of Hematology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, University Paris Diderot, Paris, France;
Blood ; 125(24): 3711-9, 2015 Jun 11.
Article en En | MEDLINE | ID: mdl-25878120

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piperazinas / Pirimidinas / Benzamidas / Cromosoma Filadelfia / Protocolos de Quimioterapia Combinada Antineoplásica / Inhibidores de Proteínas Quinasas / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2015 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piperazinas / Pirimidinas / Benzamidas / Cromosoma Filadelfia / Protocolos de Quimioterapia Combinada Antineoplásica / Inhibidores de Proteínas Quinasas / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2015 Tipo del documento: Article